Global Pharma

February 8, 2018 4:41 am Published by

Global Pharma Consulting provides services in business development, market entry and regulatory affairs for Swedish / Scandinavian and European Life Science companies seeking to establish their business in the MENA-region (Middle East / North Africa region).

By collaborating with Global Pharma Consulting, clients have a faster, smoother route to market entry, benefiting from our vast insight into today’s Life Science sector, our deep understanding of the business environment and our extensive network in these countries. Our competitive advantage lies in our ability to consult on the full spectrum of Life Science products and services, including E-Health, medtech, pharmaceutical, generics, laboratory devices, diagnostic, food supplements and cosmetics / derma products, hospital management, patient/quality registries etc. We also understand the multi-faceted approach required to do business in the MENA region and our clients have peace of mind knowing that we keep the business strategy linguistically, culturally and commercially relevant, leaving them to focus on their new networks and footprint.

Our research ensures clients make informed decisions and we keep abreast of technology and other trends shaping the sector to facilitate the right B2B networking opportunities. From meetings with decision makers, to tenders, registration processes and translation services, clients get comprehensive and affordable business support with quick implementation timelines. We continually add new services as the need arises and we believe in developing agile strategies that allow our clients to respond quickly and proactively.

Life Science companies that are already established in the Middle East/North Africa use Global Pharma Consulting’s expertise to ensure business continuity and market growth. Regardless of how complex or simple the needs are, Global Pharma Consulting approaches each project with a high level of personalization and attention to detail.

Categorised in:

This post was written by pra